Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin

This publication has 12 references indexed in Scilit:

• CMV reactivation in nonmyeloablative HSCT
  Bone Marrow Transplantation, 2001
• Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan
  Bone Marrow Transplantation, 2001
• High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation
  Bone Marrow Transplantation, 2000
• Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin
  Bone Marrow Transplantation, 2000
• Morphological analysis of microparticle generation in heparin-induced thrombocytopenia
  Blood, 2000
• Reduced risk of persisting cytomegalovirus pp65 antigenemia and cytomegalovirus interstitial pneumonia following allogeneic PBSCT
  Bone Marrow Transplantation, 2000
• Engraftment Kinetics After Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation: Full Donor T-Cell Chimerism Precedes Alloimmune Responses
  Blood, 1999
• Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.
  Journal of Clinical Oncology, 1998
• Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
  Blood, 1998
• Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV‐associated disease after bone marrow transplantation
  British Journal of Haematology, 1994